Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 317
Filter
1.
Toxicology ; 426: 152255, 2019 10 01.
Article in English | MEDLINE | ID: mdl-31401084

ABSTRACT

DNA fragmentation factor 40 (DFF40), an endonuclease, mediates the final and irreversible step of apoptosis by conducting oligonucleosomal DNA fragmentation. New emerging studies have proposed a role of DFF40 in genomic stability, besides its nuclease activity. Overexpression of DFF40 in tumoral cells increases their sensitivity to chemotherapeutic drugs. In this study, we sought to determine if DFF40 expression influences the toxicity of tributyltin (TBT), a well-known immunotoxic and apoptosis-inducing compound. The strategy used was to knockout DFF40 expression by CRISPR-cas9 method in Jurkat T cells and to determine the toxicity of TBT in DFF40 KO cells and DFF40 WT Jurkat cells. DFF40 KO Jurkat cells show an increase of cell viability following a 24-h TBT exposure (p < 0.05). There is a resistance to TBT-induced apoptosis determined by annexin V/PI am labeling (p < 0.05). Interestingly, the basal level of ROS rises in DFF40 KO Jurkat cells, but ROS production levels after TBT exposure remains at the same basal level. Other apoptosis or DNA damage makers (procaspase-3, caspase-6, and PARP cleavage) are significantly delayed and decreased. DFF40 deficient cells do not present histone H2AX phosphorylation, whereas wild-type cells present a phosphorylation following a 6-h exposure to TBT (p < 0.001). The re-expression of DFF40 in DFF40 KO cells restores the cytotoxic effects of TBT. Overall, these data suggest a role of DFF40 in cells sensitivity to TBT and possibly in DNA stability.


Subject(s)
Apoptosis/drug effects , Deoxyribonucleases/biosynthesis , Poly-ADP-Ribose Binding Proteins/biosynthesis , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Trialkyltin Compounds/toxicity , Caspases/metabolism , Cell Line, Tumor , DNA Damage/drug effects , Gene Knockout Techniques , Histones/metabolism , Humans , Jurkat Cells , Phosphorylation , Reactive Oxygen Species/metabolism
2.
Int J Gynecol Pathol ; 37(5): 431-440, 2018 Sep.
Article in English | MEDLINE | ID: mdl-28914671

ABSTRACT

DNA fragmentation factor 40 (DFF40) is a key executor of apoptosis. It localizes to the nucleus together with DNA fragmentation factor 45 (DFF45), which acts as a DFF40 inhibitor and chaperone. B-cell lymphoma (Bcl-2) protein is a proven antiapoptotic factor present in the cytoplasm. In this study, we aimed to investigate DFF40, DFF45, and Bcl-2 immunoexpression in endometrial polyps (EPs) and benign endometrial hyperplasia (BEH) tissue compared with that in normal proliferative endometrium (NPE) and normal secretory endometrium (NSE) as well as normal post menopausal endometrium (NAE). This study used archived samples from 65 and 62 cases of EPs and BEH, respectively. The control group consisted of 52 NPE, 54 NSE, and 54 NAE specimens. Immunohistochemistry was used to detect DFF40, DFF45, and Bcl-2. DFF40, DFF45, and Bcl-2 were more highly expressed in the glandular layer of EPs and BEH compared with the stroma, and this was not influenced by menopausal status. Both glandular and stromal expression of DFF40, DFF45, and Bcl-2 were significantly higher in EPs compared with NPE, NSE, and NAE. Glandular BEH tissue showed significantly higher DFF40, DFF45, and Bcl-2 expression than in NPE, NSE, and NAE. No differences in the glandular expression of DFF40, DFF45, and Bcl-2 were observed between EP and BEH tissues, while Bcl-2 stromal expression in BEH was significantly lower than in EPs. Glandular, menopause-independent DFF40, DFF45, and Bcl-2 overexpression may play an important role in the pathogenesis of EPs and BEH.


Subject(s)
Apoptosis Regulatory Proteins/biosynthesis , Deoxyribonucleases/biosynthesis , Endometrial Hyperplasia/metabolism , Poly-ADP-Ribose Binding Proteins/biosynthesis , Polyps/metabolism , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Uterine Diseases/metabolism , Adult , Case-Control Studies , Female , Humans , Middle Aged , Retrospective Studies
3.
J Biosci ; 41(4): 589-600, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27966482

ABSTRACT

The hypothetical protein 'Alr3200' of Anabaena sp. strain PCC7120 is highly conserved among cyanobacterial species. It is a member of the DUF820 (Domain of Unknown Function) protein family, and is predicted to have a DNase domain. Biochemical analysis revealed a Mg(II)-dependent DNase activity for Alr3200 with a specific activity of 8.62x104 Kunitz Units (KU) mg -1 protein. Circular dichroism analysis predicted Alr3200 to have approximately 40 percent beta-strands and approximately 9 percent alpha-helical structures. Anabaena PCC7120 inherently expressed Alr3200 at very low levels, and its overexpression had no significant effect on growth of Anabaena under control conditions. However, Analr3200+, the recombinant Anabaena strain overexpressing Alr3200, exhibited zero survival upon exposure to 6 kGy of gamma-radiation, which is the LD50 for wild type Anabaena PCC7120 as well as the vector control recombinant strain, AnpAM. Comparative analysis of the two recombinant Anabaena strains suggested that it is not the accumulated Alr3200 per se, but its possible interactions with the radiation-induced unidentified DNA repair proteins of Anabaena, which hampers DNA repair resulting in radiosensitivity.


Subject(s)
Anabaena/chemistry , Bacterial Proteins/chemistry , Deoxyribonucleases/chemistry , Anabaena/genetics , Bacterial Proteins/genetics , Circular Dichroism , DNA Repair/genetics , Deoxyribonucleases/biosynthesis , Gene Expression Regulation, Bacterial , Protein Conformation, alpha-Helical , Protein Conformation, beta-Strand
4.
Arch Oral Biol ; 66: 61-5, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26913969

ABSTRACT

The colonization by Candida species is one of the most important factors related to the development of oral candidiasis in HIV-infected individuals. The aim of the study was to evaluate and discuss the phospholipase, proteinase, DNAse and haemolytic activities of Candida albicans isolated from the oral cavity of HIV individuals with high efficiency antiretroviral therapy. Seventy-five isolates of C. albicans obtained from saliva samples of patients with HIV and 41 isolates from HIV-negative individuals were studied. Haemolytic activity was determined in Sabouraud dextrose agar plates containing 3% glucose and 7% sheep red cells. Culture medium containing DNA base-agar, egg yolk, and bovine albumin were used to determine DNase, phospholipase and proteinase activities, respectively. All isolates from the HIV patients group had haemolytic activity, 98% showed phospholipase activity, 92% were positive for proteinase and 32% DNAse activity. Regarding the group of indivídios HIV negative, all 41 isolates presented hemolytic activity, 90.2% showed phospholipase and proteinase activity and 12.2% were positive for DNAse. The phospholipase activity was more intense for the group of HIV positive individuals. DNase production was more frequently observed in the group of HIV-positive individuals. The percentage of isolates having DNAse activity was also significantly different between the groups of patients not using any antiretroviral therapy, those using transcriptase inhibitors and those using transcriptase inhibitor and protease inhibitor in combination.


Subject(s)
Antiretroviral Therapy, Highly Active , Candida albicans/isolation & purification , Candida albicans/metabolism , Candidiasis, Oral/microbiology , HIV Infections/drug therapy , HIV Infections/microbiology , Virulence Factors/metabolism , Anti-Retroviral Agents/pharmacology , Candida albicans/enzymology , Candida albicans/pathogenicity , Candidiasis, Oral/virology , Culture Media , DNA-Directed RNA Polymerases , Deoxyribonucleases/biosynthesis , Enzyme Activation , HIV Infections/virology , Humans , Mouth/microbiology , Peptide Hydrolases/biosynthesis , Phospholipases/biosynthesis , Protease Inhibitors , Saliva/microbiology
5.
Mutat Res ; 776: 2-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26255934

ABSTRACT

Xeroderma pigmentosum (XP) is a genetic disease characterized by hypersensitivity to ultra-violet and a very high risk of skin cancer induction on exposed body sites. This syndrome is caused by germinal mutations on nucleotide excision repair genes. No cure is available for these patients except a complete protection from all types of UV radiations. We reviewed the various techniques to complement or to correct the genetic defect in XP cells. We, particularly, developed the correction of XP-C skin cells using the fidelity of the homologous recombination pathway during repair of double-strand break (DSB) in the presence of XPC wild type sequences. We used engineered nucleases (meganuclease or TALE nuclease) to induce a DSB located at 90 bp of the mutation to be corrected. Expression of specific TALE nuclease in the presence of a repair matrix containing a long stretch of homologous wild type XPC sequences allowed us a successful gene correction of the original TG deletion found in numerous North African XP patients. Some engineered nucleases are sensitive to epigenetic modifications, such as cytosine methylation. In case of methylated sequences to be corrected, modified nucleases or demethylation of the whole genome should be envisaged. Overall, we showed that specifically-designed TALE-nuclease allowed us to correct a 2 bp deletion in the XPC gene leading to patient's cells proficient for DNA repair and showing normal UV-sensitivity. The corrected gene is still in the same position in the human genome and under the regulation of its physiological promoter. This result is a first step toward gene therapy in XP patients.


Subject(s)
DNA Breaks, Double-Stranded , DNA Repair , Deoxyribonucleases , Genetic Therapy , Genome, Human , Xeroderma Pigmentosum/therapy , Animals , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Deoxyribonucleases/biosynthesis , Deoxyribonucleases/genetics , Humans , Skin/metabolism , Skin/pathology , Ultraviolet Rays/adverse effects , Xeroderma Pigmentosum/genetics , Xeroderma Pigmentosum/metabolism
6.
Hypertension ; 65(4): 871-81, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25646292

ABSTRACT

Caspase-activated DNase (CAD) is a double-strand-specific endonuclease that is responsible for the cleavage of nucleosomal spacer regions and subsequent chromatin condensation during apoptosis. Given that several endonucleases (eg, DNase I, DNase II, and Endog) have been shown to regulate pathological cardiac hypertrophy, we questioned whether CAD, which is critical for the induction of DNA fragmentation, plays a pivotal role in pressure overload-elicited cardiac hypertrophy. A CAD-knockout mouse model was generated and subjected to aortic banding for 8 weeks. The extent of cardiac hypertrophy was evaluated by echocardiography and pathological and molecular analyses. Our results demonstrated that the disruption of CAD attenuated pressure overload-induced cardiac hypertrophy, fibrosis, and cardiac dysfunction. Conversely, transgenic mice with cardiac-specific overexpression of CAD showed an aggravated cardiac hypertrophic response to chronic pressure overload. Mechanistically, we discovered that the expression and activation of mitogen-activated protein kinase-extracellular signal-regulated kinase 1/2 was significantly reduced in the CAD-knockout hearts compared with the control hearts; however, they were greatly increased in the CAD-overexpressing hearts after aortic banding. Similar results were observed in ex vivo cultured neonatal rat cardiomyocytes after treatment with angiotensin II for 48 hours. These data indicate that CAD functions as a necessary modulator of the hypertrophic response by regulating the mitogen-activated protein kinase-extracellular signal-regulated kinase 1/2 signaling pathway in the heart. Our study suggests that CAD might be a novel target for the treatment of pathological cardiac hypertrophy and heart failure.


Subject(s)
Cardiomegaly/genetics , Deoxyribonucleases/genetics , Gene Expression Regulation , Myocytes, Cardiac/pathology , RNA/genetics , Animals , Apoptosis , Blotting, Western , Cardiomegaly/diagnosis , Cardiomegaly/metabolism , Cells, Cultured , Deoxyribonucleases/biosynthesis , Disease Models, Animal , Echocardiography , Female , Humans , Male , Mice , Mice, Inbred C57BL , Myocytes, Cardiac/metabolism , Rats , Real-Time Polymerase Chain Reaction , Signal Transduction , Ventricular Function, Left/physiology
7.
Proc Natl Acad Sci U S A ; 111(25): 9253-8, 2014 Jun 24.
Article in English | MEDLINE | ID: mdl-24927536

ABSTRACT

Hemophilia A, one of the most common genetic bleeding disorders, is caused by various mutations in the blood coagulation factor VIII (F8) gene. Among the genotypes that result in hemophilia A, two different types of chromosomal inversions that involve a portion of the F8 gene are most frequent, accounting for almost half of all severe hemophilia A cases. In this study, we used a transcription activator-like effector nuclease (TALEN) pair to invert a 140-kbp chromosomal segment that spans the portion of the F8 gene in human induced pluripotent stem cells (iPSCs) to create a hemophilia A model cell line. In addition, we reverted the inverted segment back to its normal orientation in the hemophilia model iPSCs using the same TALEN pair. Importantly, we detected the F8 mRNA in cells derived from the reverted iPSCs lines, but not in those derived from the clones with the inverted segment. Thus, we showed that TALENs can be used both for creating disease models associated with chromosomal rearrangements in iPSCs and for correcting genetic defects caused by chromosomal inversions. This strategy provides an iPSC-based novel therapeutic option for the treatment of hemophilia A and other genetic diseases caused by chromosomal inversions.


Subject(s)
Chromosome Inversion , Deoxyribonucleases/biosynthesis , Factor VIII/genetics , Gene Targeting/methods , Hemophilia A , Induced Pluripotent Stem Cells/metabolism , Models, Biological , Deoxyribonucleases/genetics , Factor VIII/metabolism , HEK293 Cells , Hemophilia A/genetics , Hemophilia A/metabolism , Hemophilia A/pathology , Humans , Induced Pluripotent Stem Cells/pathology
8.
Hum Gene Ther ; 25(7): 599-608, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24568341

ABSTRACT

Integrase-defective lentiviral vectors (IDLVs) have been of limited success in the delivery of zinc finger nucleases (ZFNs) to human cells, due to low expression. A reason for reduced gene expression has been proposed to involve the epigenetic silencing of vector genomes, carried out primarily by histone deacetylases (HDACs). In this study, we tested valproic acid (VPA), a known HDAC inhibitor (HDACi), for its ability to increase transgene expression from IDLVs, especially in the context of ZFN delivery. Using ZFNs targeting the human adenosine deaminase (ADA) gene in K562 cells, we demonstrated that treatment with VPA enhanced ZFN expression by up to 3-fold, resulting in improved allelic disruption at the ADA locus. Furthermore, three other U.S. Food and Drug Administration-approved HDACis (vorinostat, givinostat, and trichostatin-A) exhibited a similar effect on the activity of ZFN-IDLVs in K562 cells. In primary human CD34(+) cells, VPA- and vorinostat-treated cells showed higher levels of expression of both green fluorescent protein (GFP) as well as ZFNs from IDLVs. A major mechanism for the effects of HDAC inhibitors on improving expression was from their modulation of the cell cycle, and the influence of heterochromatinization was determined to be a lesser contributing factor.


Subject(s)
Deoxyribonucleases , Genetic Vectors , Histone Deacetylase Inhibitors/pharmacology , Integrases , Lentivirus , Transduction, Genetic , Viral Proteins , Deoxyribonucleases/biosynthesis , Deoxyribonucleases/genetics , Humans , K562 Cells , Zinc Fingers
9.
PLoS One ; 8(11): e75493, 2013.
Article in English | MEDLINE | ID: mdl-24223114

ABSTRACT

Zinc Finger Nucleases (ZFNs), famous for their ability to precisely and efficiently modify specific genomic loci, have been employed in numerous transgenic model organism and cell constructions. Here we employ the ZFNs technology, with homologous recombination (HR), to construct sequence-specific Amyloid Precursor Protein (APP) knock-in cells. With the use of ZFNs, we established APP knock in cell lines with gene-modification efficiencies of about 7%. We electroporated DNA fragment containing the promoter and the protein coding regions of the zinc finger nucleases into cells, instead of the plasmids, to avoid problems associated with off target homologous recombination, and adopted a pair of mutated FokI cleavage domains to reduce the toxic effects of the ZFNs on cell growth. Since over-expression of APP, or a subdomain of it, might lead to an immediately lethal effect, we used the Cre-LoxP System to regulate APP expression. Our genetically transformed cell lines, w5c1 and s12c8, showed detectable APP and Amyloid ß (Aß) production. The Swedish double mutation in the APP coding sequence enhanced APP and Aß abundance. What is more, the activity of the three key secretases in Aß formation could be modulated, indicating that these transgenic cells have potential for drug screening to modify amyloid metabolism in cells. Our transformed cells could readily be propagated in culture and should provide an excellent experimental medium for elucidating aspects of the molecular pathogenesis of Alzheimer's disease, especially those concerning the amyloidogenic pathways involving mutations in the APP coding sequence. The cellular models may also serve as a tool for deriving potentially useful therapeutic agents.


Subject(s)
Alzheimer Disease/drug therapy , Amyloid beta-Peptides/genetics , Deoxyribonucleases/genetics , Peptide Fragments/genetics , Amyloid beta-Peptides/biosynthesis , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Apoptosis , BALB 3T3 Cells , Base Sequence , Cholinesterase Inhibitors/pharmacology , DNA Cleavage , Deoxyribonucleases/biosynthesis , Donepezil , Drug Evaluation, Preclinical , Galantamine/pharmacology , Gene Expression , Genetic Engineering , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Homologous Recombination , Humans , Ibuprofen/pharmacology , Indans/pharmacology , Mice , Molecular Sequence Data , Peptide Fragments/biosynthesis , Piperidines/pharmacology , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Zinc Fingers
10.
Bioresour Technol ; 130: 552-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23334010

ABSTRACT

The extracellular nuclease, NucB, from Bacillus licheniformis, can digest extracellular DNA in biofilms, causing biofilm dispersal, and may therefore be used commercially to remove biofilms. However, producing quantities of this secreted peptide is difficult and our aim was therefore to improve its laboratory scale production. This study builds on our understanding of B. licheniformis physiology to enhance NucB production. The addition of manganese, which triggers sporulation and enhances NucB expression, lead to a 5-fold increase in NucB production. Optimisation via Placket-Burman design of experiments identified 3 significant medium components and a subsequent Central Composite Design, to determine the optimum levels of these components, resulted in a 10-fold increase to 471U/ml. The optimal phosphate concentration was less than 0.3mM as this is known to inhibit nuclease production. The use of physiologically relevant information combined with optimisation represents a promising approach to increased enzyme production, which may also be widely applicable.


Subject(s)
Bacillus/physiology , Bacterial Proteins/biosynthesis , Cell Culture Techniques , Deoxyribonucleases/biosynthesis , Bacterial Proteins/metabolism , Biofilms/growth & development , Culture Media , Deoxyribonucleases/metabolism , Manganese/metabolism , Phosphates/metabolism
11.
Stem Cells Dev ; 22(4): 595-610, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-22931452

ABSTRACT

Zinc finger nucleases (ZFNs) have become powerful tools to deliver a targeted double-strand break at a pre-determined chromosomal locus in order to insert an exogenous transgene by homology-directed repair. ZFN-mediated gene targeting was used to generate both single-allele chemokine (C-C motif) receptor 5 (CCR5)-modified human induced pluripotent stem cells (hiPSCs) and biallele CCR5-modified hiPSCs from human lung fibroblasts (IMR90 cells) and human primary cord blood mononuclear cells (CBMNCs) by site-specific insertion of stem cell transcription factor genes flanked by LoxP sites into the endogenous CCR5 locus. The Oct4 and Sox2 reprogramming factors, in combination with valproic acid, induced reprogramming of human lung fibroblasts to form CCR5-modified hiPSCs, while 5 factors, Oct4/Sox2/Klf4/Lin28/Nanog, induced reprogramming of CBMNCs. Subsequent Cre recombinase treatment of the CCR5-modified IMR90 hiPSCs resulted in the removal of the Oct4 and Sox2 transgenes. Further genetic engineering of the single-allele CCR5-modified IMR90 hiPSCs was achieved by site-specific addition of the large CFTR transcription unit to the remaining CCR5 wild-type allele, using CCR5-specific ZFNs and a donor construct containing tdTomato and CFTR transgenes flanked by CCR5 homology arms. CFTR was expressed efficiently from the endogenous CCR5 locus of the CCR5-modified tdTomato/CFTR hiPSCs. These results suggest that it might be feasible to use ZFN-evoked strategies to (1) generate precisely targeted genetically well-defined patient-specific hiPSCs, and (2) then to reshape their function by targeted addition and expression of therapeutic genes from the CCR5 chromosomal locus for autologous cell-based transgene-correction therapy to treat various recessive monogenic human diseases in the future.


Subject(s)
Cell Dedifferentiation , Deoxyribonucleases , Fibroblasts , Genetic Engineering , Induced Pluripotent Stem Cells , Leukocytes, Mononuclear , Transcription Factors , Zinc Fingers , Deoxyribonucleases/biosynthesis , Deoxyribonucleases/genetics , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Targeting , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/metabolism , Kruppel-Like Factor 4 , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/metabolism , Transcription Factors/biosynthesis , Transcription Factors/genetics
12.
Mol Biol Cell ; 23(4): 567-76, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22171325

ABSTRACT

Mitotic arrest induced by antimitotic drugs can cause apoptosis or p53-dependent cell cycle arrest. It can also cause DNA damage, but the relationship between these events has been unclear. Live, single-cell imaging in human cancer cells responding to an antimitotic kinesin-5 inhibitor and additional antimitotic drugs revealed strong induction of p53 after cells slipped from prolonged mitotic arrest into G1. We investigated the cause of this induction. We detected DNA damage late in mitotic arrest and also after slippage. This damage was inhibited by treatment with caspase inhibitors and by stable expression of mutant, noncleavable inhibitor of caspase-activated DNase, which prevents activation of the apoptosis-associated nuclease caspase-activated DNase (CAD). These treatments also inhibited induction of p53 after slippage from prolonged arrest. DNA damage was not due to full apoptosis, since most cytochrome C was still sequestered in mitochondria when damage occurred. We conclude that prolonged mitotic arrest partially activates the apoptotic pathway. This partly activates CAD, causing limited DNA damage and p53 induction after slippage. Increased DNA damage via caspases and CAD may be an important aspect of antimitotic drug action. More speculatively, partial activation of CAD may explain the DNA-damaging effects of diverse cellular stresses that do not immediately trigger apoptosis.


Subject(s)
Apoptosis/physiology , Cell Cycle Checkpoints/physiology , DNA Damage/physiology , Mitosis/physiology , Tumor Suppressor Protein p53/metabolism , Antimitotic Agents/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Deoxyribonucleases/biosynthesis , Humans , Kinesins/antagonists & inhibitors , Mitosis/drug effects , Mitosis/genetics , Quinolines/pharmacology
13.
PLoS Pathog ; 7(4): e1002020, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21533216

ABSTRACT

HIV-1 entry requires the cell surface expression of CD4 and either the CCR5 or CXCR4 coreceptors on host cells. Individuals homozygous for the ccr5Δ32 polymorphism do not express CCR5 and are protected from infection by CCR5-tropic (R5) virus strains. As an approach to inactivating CCR5, we introduced CCR5-specific zinc-finger nucleases into human CD4+ T cells prior to adoptive transfer, but the need to protect cells from virus strains that use CXCR4 (X4) in place of or in addition to CCR5 (R5X4) remains. Here we describe engineering a pair of zinc finger nucleases that, when introduced into human T cells, efficiently disrupt cxcr4 by cleavage and error-prone non-homologous DNA end-joining. The resulting cells proliferated normally and were resistant to infection by X4-tropic HIV-1 strains. CXCR4 could also be inactivated in ccr5Δ32 CD4+ T cells, and we show that such cells were resistant to all strains of HIV-1 tested. Loss of CXCR4 also provided protection from X4 HIV-1 in a humanized mouse model, though this protection was lost over time due to the emergence of R5-tropic viral mutants. These data suggest that CXCR4-specific ZFNs may prove useful in establishing resistance to CXCR4-tropic HIV for autologous transplant in HIV-infected individuals.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Deoxyribonucleases/immunology , HIV Infections/immunology , HIV-1/immunology , Receptors, CXCR4/immunology , Animals , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/transplantation , Cell Proliferation , Deoxyribonucleases/biosynthesis , Deoxyribonucleases/genetics , Disease Models, Animal , Genetic Engineering , HIV Infections/genetics , HIV Infections/metabolism , HIV Infections/therapy , HIV-1/genetics , HIV-1/metabolism , Humans , Macaca mulatta , Mice , Receptors, CCR5/genetics , Receptors, CCR5/immunology , Receptors, CCR5/metabolism , Receptors, CXCR4/genetics , Receptors, CXCR4/metabolism , Transplantation, Autologous , Transplantation, Heterologous , Virus Internalization
14.
J Plant Physiol ; 167(13): 1093-100, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20447722

ABSTRACT

The ability of cells to control the degradation of their own DNA is a common feature of most living organisms. In plants, extensive hydrolysis of nuclear DNA occurs during different forms of programmed cell death (PCD). In addition to the removal of unwanted cells, the PCD process allows for the remobilization of cellular constituents, including the products of DNA hydrolysis. Although programmed cell death occurs widely during normal development and plant defense responses to pathogens, only one class of deoxyribonucleases, the S1 type, involved in these processes, has been well characterized. Using DNA-SDS-PAGE, we identified the activities of 14 deoxyribonucleases expressed in different organs of cauliflower seeds, seedlings and the flower head. These enzymes represent several classes based on their substrate specificity and ion dependency. In addition to four Zn(2+)-dependent enzymes, we identified five Ca(2+)-dependent, two Mg(2+)-dependent, three Ca(2+)/Mg(2+)-dependent and one nuclease whose activities seem to be independent of any divalent cations. We also identified a set of DNases whose expression seems to be common for different organs and different stages of development, as well as a few highly tissue-specific nucleases. Expression of three nucleases was inducible by drought stress and hydrogen peroxide.


Subject(s)
Brassica/enzymology , Brassica/growth & development , Deoxyribonucleases/metabolism , Seedlings/enzymology , Seedlings/growth & development , Brassica/drug effects , Cotyledon/drug effects , Cotyledon/enzymology , Cotyledon/growth & development , Deoxyribonucleases/biosynthesis , Droughts , Electrophoresis, Polyacrylamide Gel , Enzyme Induction/drug effects , Hydrogen Peroxide/pharmacology , Organ Specificity/drug effects , Plant Leaves/enzymology , Plant Leaves/growth & development , Seedlings/drug effects , Stress, Physiological/drug effects
15.
J Bacteriol ; 192(4): 936-41, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20023031

ABSTRACT

The species Campylobacter jejuni is naturally competent for DNA uptake; nevertheless, nonnaturally transformable strains do exist. For a subset of strains we previously showed that a periplasmic DNase, encoded by dns, inhibits natural transformation in C. jejuni. In the present study, genetic factors coding for DNase activity in the absence of dns were identified. DNA arrays indicated that nonnaturally transformable dns-negative strains contain putative DNA/RNA nonspecific endonucleases encoded by CJE0566 and CJE1441 of strain RM1221. These genes are located on C. jejuni integrated elements 2 and 4. Expression of CJE0566 and CJE1441 from strain RM1221 and a homologous gene from strain 07479 in DNase-negative Escherichia coli and C. jejuni strains indicated that these genes code for DNases. Genetic transfer of the genes to a naturally transformable C. jejuni strain resulted in a decreased efficiency of natural transformation. Modeling suggests that the C. jejuni DNases belong to the Serratia nuclease family. Overall, the data indicate that the acquisition of prophage-encoded DNA/RNA nonspecific endonucleases inhibits the natural transformability of C. jejuni through hydrolysis of DNA.


Subject(s)
Campylobacter jejuni/enzymology , Campylobacter jejuni/genetics , DNA, Bacterial/metabolism , Deoxyribonucleases/biosynthesis , Prophages/enzymology , Prophages/genetics , Transformation, Bacterial , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Deoxyribonucleases/genetics , Escherichia coli/genetics , Gene Expression Profiling , Genes, Bacterial , Genes, Viral , Models, Molecular , Protein Structure, Tertiary , RNA, Bacterial/metabolism , Serratia/genetics
16.
Roum Arch Microbiol Immunol ; 68(1): 27-33, 2009.
Article in English | MEDLINE | ID: mdl-19507624

ABSTRACT

The discovery of intra- and intercellular communication systems (quorum sensing systems) regulating bacterial virulence has afforded a novel opportunity to control infectious bacteria, without interfering with their growth. In this study, we investigated the ability of subinhibitory concentrations (sIC) of phenyl lactic acid (PLA), known to be produced by Lactobacillus probiotic strains, to attenuate the virulence and pathogenicity of Pseudomonas aeruginosa (as experimental model of intercellular bacterial communication in Gram-negative bacteria) and Staphylococcus aureus (as experimental model of intercellular bacterial communication in Gram-positive bacteria) by interfering with the coordinated expression of different virulence factors implicated in the pathogenicity of these opportunistic strains. Our results showed that sIC of PLA decreased the ability of the tested strains to adhere both to the cellular and inert substrata and induced changes in the adherence patterns as well as in the cell morphology. The sIC of PLA induced a significant decrease of sheep red blood cells haemolysins, lecithinase and caseinase and stimulated lipase and gelatinase production by Pseudomonas strains. The sIC of PLA induced an important and constant increase of the Pseudomonas growth inhibition zones diameters for all tested antibiotics, demonstrating the potential use of PLA in the design of new synergic antimicrobial associations active on multiresistant and biofilm-growing P, aeruginosa strains. The present study has proved the role of sIC of PLA released by Lactobacillus probiotic strains in the attenuation of P. aeruginosa and S. aureus virulence and pathogenicity, by interfering with different processes depending on cell density and regulated by quorum sensing (i.e. growth rate, expression of adhesion molecules and secretion of soluble, enzymatic factors) and altering the success of these pathogens in the colonization of a sensitive host and the development of an infectious process. Our results demonstrate that this probiotic soluble products could be used as a new, ecological anti-infective strategy with great therapeutic and preventive value in the biomedical field (especially in the treatment of chronic infections produced by multiresistant and biofilm forming microorganisms), but also in the management of the environmental quality, agriculture and industrial field by reducing the chemical burden delivered in the external medium and by preventing the surfaces colonization with microorganisms and the development of natural biofilms.


Subject(s)
Lactates/administration & dosage , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/metabolism , Staphylococcus aureus/drug effects , Staphylococcus aureus/metabolism , Virulence Factors/biosynthesis , Animals , Anti-Bacterial Agents/pharmacology , Bacterial Adhesion/drug effects , Deoxyribonucleases/biosynthesis , Gelatinases/biosynthesis , Hemolysin Proteins/biosynthesis , Lactobacillus/metabolism , Lipase/biosynthesis , Metalloendopeptidases/biosynthesis , Microbial Sensitivity Tests , Phospholipases/biosynthesis , Pseudomonas Infections/microbiology , Pseudomonas Infections/prevention & control , Pseudomonas aeruginosa/pathogenicity , Quorum Sensing , Sheep , Staphylococcal Infections/microbiology , Staphylococcal Infections/prevention & control , Staphylococcus aureus/pathogenicity , Virulence/drug effects
17.
Neurochem Res ; 33(7): 1232-7, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18253826

ABSTRACT

We have previously shown that hypoxia results in increased activity of caspase-9, caspase-3 and fragmentation of nuclear DNA in the cerebral cortex of newborn piglets. The present study tested the hypothesis that mechanism of DNA fragmentation during hypoxia in the cerebral cortex of newborn piglets is mediated by caspase-9-dependent caspase-3 activation. Newborn piglets were randomly assigned to normoxic, hypoxic, and hypoxic pretreated with a highly selective caspase-9 inhibitor, Z-LEHD-FMK groups. The data showed that cerebral tissue hypoxia results in increased expression of caspase-activated DNase (CAD) protein in the nucleus and fragmentation of nuclear DNA. A pretreatment with Z-LEHD-FMK attenuated the expression of CAD protein in the nucleus and the fragmentation of nuclear DNA. Based on these results, we conclude that the mechanism by which the nuclear DNA was fragmented is mediated by caspase-9-dependent caspase-3 activation and the consequence of caspase-activated DNase activation in the cerebral cortex of newborn piglets.


Subject(s)
Animals, Newborn/physiology , Cerebral Cortex/metabolism , DNA Fragmentation , Hypoxia/metabolism , Adenosine Triphosphate/metabolism , Animals , Apoptosis Regulatory Proteins/biosynthesis , Apoptosis Regulatory Proteins/genetics , Caspase 3/metabolism , Caspase 9/physiology , Caspase Inhibitors , Cell Nucleus/drug effects , Cell Nucleus/enzymology , Cell Nucleus/metabolism , Cytosol/drug effects , Cytosol/enzymology , Cytosol/metabolism , Deoxyribonucleases/biosynthesis , Deoxyribonucleases/genetics , Electrophoresis, Agar Gel , Enzyme Activation/physiology , Enzyme Inhibitors/pharmacology , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Neurons/ultrastructure , Oligopeptides/pharmacology , Phosphocreatine/metabolism , Swine
18.
Microbiology (Reading) ; 153(Pt 7): 2281-2288, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17600072

ABSTRACT

Available tools for genetic analysis in the anaerobic rumen bacterium Prevotella bryantii are limited to only two known systems for gene delivery, and no genes, with the exception of plasmid maintenance and selection genes, have been successfully expressed from plasmids in any species of the genus Prevotella until now. It is shown here that nucB, a newly cloned nuclease gene from P. bryantii, can be controllably expressed from shuttle vector pRH3 in P. bryantii strain TC1-1, depending on the tetracycline concentration in the growth medium. nucB expression is also growth-medium dependent and this regulation presumably takes place at the translational level. His-tagged NucB was purified from P. bryantii TC1-1 culture supernatant and was shown to degrade DNA as well as RNA; it is most likely a minor 36 kDa P. bryantii non-specific nuclease.


Subject(s)
Deoxyribonucleases/biosynthesis , Prevotella/genetics , Cloning, Molecular , DNA, Bacterial/metabolism , Deoxyribonucleases/genetics , Gene Expression , Genetic Vectors/genetics , Genetic Vectors/metabolism , Molecular Sequence Data , Prevotella/enzymology , Prevotella/metabolism
19.
Article in English | MEDLINE | ID: mdl-17466554

ABSTRACT

The presence of neutral DNase activity in bivalves is reported for the first time. The enzyme activity in four tissues of the mussel Mytilus galloprovincialis was analyzed by three different methods (i) specific denaturating SDS-PAGE zymogram, (ii) sensitive single radial enzyme diffusion (SRED) assay and (iii) rapid and sensitive fluorimetric determination of DNase activity with PicoGreen. The fluorimetric assay was rapid and sensitive enough for determination of hydrolytic activity of dsDNA in mussel hepatopancreas, adductor, gills and mantle. Maximal activity in all mussel tissue extracts was obtained in the presence of Ca(2+) and Mg(2+) at pH 7.0 with dsDNA as substrate. The neutral DNase activity in mussel tissue decreases in order hepatopancreas, mantle>gills>adductor. The enzyme activity displays interindividual variability in particular tissue as well as variability among tissues within one specimen. In the hepatopancreas one to three distinct proteins expressing neutral, Ca(2+), Mg(2+)-dependent, DNase activity were detected by denaturating SDS-PAGE zymogram. This heterogeneity of neutral nucleases involved in DNA hydrolysis in hepatopancreas could reflect interindividual variability in mussel food utilization and nutrient requirement.


Subject(s)
Deoxyribonucleases/biosynthesis , Gene Expression Regulation, Enzymologic/physiology , Mytilus/enzymology , Animals , Calcium/metabolism , Magnesium/metabolism , Organ Specificity/physiology
20.
Infect Immun ; 75(4): 1964-72, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17283102

ABSTRACT

We previously reported that the cvfB gene (SA1223) of Staphylococcus aureus is responsible for the virulence of this pathogenic bacterium. We show here that the cvfB gene regulates exoprotein gene expression. In a cvfB gene deletion mutant, hemolysin, DNase, and protease production were decreased, whereas protein A expression was increased. The amount of RNAIII, the transcript from the P3 promoter in the agr locus that regulates the expression of various virulence factors, was also reduced in the cvfB mutant. In addition, P2 and P3 promoter activity in the agr locus was decreased in the mutant. Under the genetic background of the agr-null mutation, cvfB gene disruption decreased the production levels of DNase and protease. Moreover, the cvfB and agr double mutant was less virulent than the agr mutant in silkworms. These results suggest that the cvfB gene product contributes to the expression of virulence factors and to pathogenicity via both agr-dependent and agr-independent pathways.


Subject(s)
Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial , Genes, Bacterial , Genes, Regulator , Staphylococcus aureus/genetics , Staphylococcus aureus/pathogenicity , Virulence Factors/genetics , Animals , Bacterial Proteins/biosynthesis , Bacterial Proteins/physiology , Bombyx/microbiology , Deoxyribonucleases/biosynthesis , Female , Gene Deletion , Hemolysin Proteins/biosynthesis , Mice , Peptide Hydrolases/biosynthesis , RNA, Antisense/biosynthesis , RNA, Bacterial/biosynthesis , Staphylococcal Protein A/biosynthesis , Staphylococcus aureus/metabolism , Trans-Activators/genetics , Trans-Activators/physiology , Virulence/genetics , Virulence Factors/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...